R. Kent McGaughy Jr., Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 1,200,000 shares at $25.00 ($30.0M) on 2017-06-22, disclosed to the SEC on 2017-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TIL | BUY | 2021-03-25 | $9.0M | — | Filing → |
| APEN | BUY | 2020-07-21 | $2.2M | — | Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |